Sagimet Biosciences Inc (SGMT)
4.32
-0.13
(-2.92%)
USD |
NASDAQ |
May 03, 16:00
4.32
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Total Liabilities (Quarterly): 5.654M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.654M |
| September 30, 2023 | 5.05M |
| June 30, 2023 | 219.91M |
| Date | Value |
|---|---|
| March 31, 2023 | 219.95M |
| December 31, 2022 | 219.98M |
| March 31, 2021 | 217.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.05M
Minimum
Sep 2023
219.98M
Maximum
Dec 2022
148.06M
Average
218.85M
Median
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| 89bio Inc | 59.96M |
| Viking Therapeutics Inc | 33.63M |
| Akero Therapeutics Inc | 44.96M |
| Arrowhead Pharmaceuticals Inc | 452.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.72M |
| Shareholders Equity (Quarterly) | 91.06M |